TMCI Stock Price, Chart, Stats & News

Treace Medical Concepts Inc (TMCI) does not currently pay a dividend.
TMCI chart
Fundamentals
Gross margin | 79.81% |
Operating margin | -25.46% |
Pretax margin | -27.74% |
Net margin | -27.74% |
Effective tax rate | – |
ROA | -30.96% |
ROE | -62.19% |
D/E | 0.16x |
Interest coverage ratio | -10.18x |
TMCI valuation
P/E | – |
P/S | 0.37x |
P/B | 0.89x |
P/CF | -4.88x |
P/FCF | -2.67x |
P/OCF | -4.88x |
PEG | 0.08x |
EV multiple | -1.76x |
About
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant.
Similar securities
Based on sector and market capitalization











